Clinical Trial Update: Safety and Efficacy of Cariprazine for Bipolar I Disorder [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the safety and efficacy of cariprazine for Bipolar I Disorder with mania; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Mania

Drugs mentioned

• VRAYLAR (cariprazine)

Snippet

Sponsor: Forest Laboratories | Conditions: Mania, Bipolar I Disorder | Phase 3 | Status: COMPLETED | Results posted: 2017-04-12